Form 4 for EDIT Editas Medicine, Inc.
Accepted 2024-06-06 00:00:00 ET · period of report 2024-06-04 · accession 0001650664-24-000076 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-06 | 2024-06-04 | EDIT | O'Neill Gilmore Neil | CEO, Dir | S - Sale | $5.50 | -12.2K | 315.3K | -4% | -$67.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-04 | S | D | 12,191 | $5.50 | 315,279 | D | — | — |